7-122302028-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001024613.4(FEZF1):āc.1397T>Gā(p.Leu466Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000263 in 1,598,204 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001024613.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FEZF1 | NM_001024613.4 | c.1397T>G | p.Leu466Arg | missense_variant | 4/4 | ENST00000442488.7 | NP_001019784.2 | |
FEZF1 | NM_001160264.2 | c.1247T>G | p.Leu416Arg | missense_variant | 5/5 | NP_001153736.1 | ||
FEZF1 | XM_005250337.4 | c.1397T>G | p.Leu466Arg | missense_variant | 5/5 | XP_005250394.1 | ||
FEZF1 | XM_011516202.3 | c.1247T>G | p.Leu416Arg | missense_variant | 6/6 | XP_011514504.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FEZF1 | ENST00000442488.7 | c.1397T>G | p.Leu466Arg | missense_variant | 4/4 | 1 | NM_001024613.4 | ENSP00000411145 | P2 | |
FEZF1 | ENST00000427185.2 | c.1247T>G | p.Leu416Arg | missense_variant | 5/5 | 1 | ENSP00000392727 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152012Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000516 AC: 12AN: 232554Hom.: 1 AF XY: 0.0000468 AC XY: 6AN XY: 128168
GnomAD4 exome AF: 0.0000138 AC: 20AN: 1446076Hom.: 1 Cov.: 31 AF XY: 0.0000153 AC XY: 11AN XY: 719634
GnomAD4 genome AF: 0.000145 AC: 22AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74374
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 14, 2024 | The c.1397T>G (p.L466R) alteration is located in exon 4 (coding exon 4) of the FEZF1 gene. This alteration results from a T to G substitution at nucleotide position 1397, causing the leucine (L) at amino acid position 466 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 28, 2022 | This variant is present in population databases (rs577039958, gnomAD 0.05%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with FEZF1-related conditions. This sequence change replaces leucine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 466 of the FEZF1 protein (p.Leu466Arg). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at